The major reason why the said letter has gained much attention from different quarters is that it was from the office of Dr. Terrence L. Boos who is the Section Chief of the Drug and Chemical Evaluation Section. The section is under the Office of Diversion Control in the DEA and this particular letter was written to the Executive Secretary of the Board of Pharmacy of Alabama who requested a control status update on delta-8 THC. This means the contents of the letter can easily be used to juxtapose the current stand of the DEA as it applies to substance control for delta-8 THC.
High Times sent Ethan Zohn across the country during the World Cup to find where…
When most people think about the FIFA World Cup, they think about moments. The winning…
As younger consumers rethink their relationship with alcohol, retailers like SWADE Cannabis are betting cannabis…
Pepper’s drummer reflects on Point Break Festival, reggae-rock’s traveling family, growing up around Hawaiian cannabis,…
The hearing that could decide weed’s federal future starts June 29. The DEA invited seven…
Robinhood is a popular US-based investment app that allows everyday individuals to buy and sell…